State of Alaska Department of Revenue’s Acadia Pharmaceuticals ACAD Stock Holding History

State of Alaska Department of Revenue’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Sell	77,445 -20,070	-21%	-$442K	0.02%	703
2026 Q1	$2.17M	Sell	97,515 -2,231	-2%	-$53.3K	0.02%	668
2025 Q4	$2.66M	Buy	99,746 +26,593	+36%	+$635K	0.03%	558
2025 Q3	$1.56M	Sell	73,153 -594	-0.8%	-$14K	0.02%	841
2025 Q2	$1.59M	Buy	73,747 +5,522	+8%	+$103K	0.02%	825
2025 Q1	$1.13M	Buy	+68,225	New	+$1.24M	0.01%	946
2018 Q2	–	Sell	-9,040	Closed	-$203K	–	1640
2018 Q1	$203K	Buy	9,040 +1,740	+24%	+$48.2K	﹤0.01%	1409
2017 Q4	$219K	Buy	+7,300	New	+$233K	0.01%	1219

Other funds holding ACAD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State of Alaska Department of Revenue's ACAD Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Acadia Pharmaceuticals (ACAD) stake by 21% in Q2 2026, selling an estimated $442K and leaving 77,445 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #703.

State of Alaska Department of Revenue first reported a position in ACAD in Q4 2017 and has held it in 8 quarters since. The position peaked at $2.66M in Q4 2025. 206 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

State of Alaska Department of Revenue held 77,445 shares of Acadia Pharmaceuticals worth $1.96M as of Q2 2026.
State of Alaska Department of Revenue sold 20,070 Acadia Pharmaceuticals shares in Q2 2026, an estimated $442K.
Acadia Pharmaceuticals made up 0.02% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #703 holding.
State of Alaska Department of Revenue first reported a position in Acadia Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
State of Alaska Department of Revenue's Acadia Pharmaceuticals position peaked at $2.66M in Q4 2025.
206 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.